Síndrome nefrótico como manifestación de microangiopatía trombótica secundaria al uso crónico de sunitinib

Síndrome nefrótico como manifestación de microangiopatía trombótica secundaria al uso crónico de sunitinib

Resumen: El síndrome nefrótico en los pacientes con cáncer se puede asociar a su enfermedad de base o al tratamiento quimioterapéutico. El cáncer de órganos sólidos puede producir una glomerulonefritis membranosa que se manifiesta con síndrome nefrótico; otras presentaciones histológicas menos frecu...

Full description

Bibliographic Details
Main Authors:	John Fredy Nieto-Ríos, Camilo Andrés García-Prada, Arbey Aristizabal-Alzate, Gustavo Zuluaga-Valencia, Dahyana Cadavid-Aljure, Lina Maria Serna-Higuita, Luis F. Arias
Format:	Article
Language:	Spanish
Published:	Elsevier 2022-11-01
Series:	Nefrología
Subjects:	Sunitinib Thrombotic microangiopathy Nephrotic syndrome GIST tumor
Online Access:	http://www.sciencedirect.com/science/article/pii/S0211699521001831

Similar Items

Nephrotic syndrome as a manifestation of thrombotic microangiopathy due to long-term use of sunitinib
by: John Fredy Nieto-Ríos, et al.
Published: (2022-11-01)

Microangiopatía trombótica en una paciente con infección por el virus de la inmunodeficiencia humana
by: Ángel Pellicer Cabo, et al.

¿Hipertensión arterial maligna con microangiopatía trombótica o nefroangioesclerosis maligna mediada por complemento, evento transitorio o permanente? A propósito de un caso
by: José de la Flor, et al.
Published: (2022-01-01)

Treatment of gastrointestinal stromal tumours in paediatric and young adult patients with sunitinib: a multicentre case series
by: Piotr Rutkowski, et al.
Published: (2017-11-01)

Development and relapse of nephrotic syndrome with thrombotic microangiopathy following repeated COVID-19 vaccination: A case report
by: Dan Inoue, et al.
Published: (2023-09-01)

Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report
by: Ryo Yamada, et al.
Published: (2019-01-01)

Renal-Limited Thrombotic Microangiopathy due to Bevacizumab Therapy for Metastatic Colorectal Cancer: A Case Report
by: Naoya Toriu, et al.
Published: (2019-06-01)

Nephrotic Syndrome and Acute Renal Failure Apparently Induced by Sunitinib
by: Ying-Shou Chen, et al.
Published: (2009-10-01)

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
by: Rutkowski Piotr, et al.
Published: (2012-03-01)

An Interesting Case: Sunitinib-Induced Microangiopathic Hemolytic Anemia and Nephrotic Syndrome
by: Veysel Haksöyler, et al.
Published: (2021-06-01)

Sunitinib-related high-grade proteinuria and allograft dysfunction in a kidney recipient: a rare case report
by: Hsu-Cheng Ko, et al.
Published: (2022-04-01)

Nephrotoxicity of anti-angiogenesis drugs
by: Katerina S. Grechukhina, et al.
Published: (2020-07-01)

Nephrotic syndrome during pregnancy. Is it chronic glomerulonephritis or preeclampsia? Case report
by: Maria V. Alekseeva, et al.
Published: (2023-08-01)

Sunitinib versus imatinib dose escalation after failure of imatinib standard dose in patients with advanced Gastrointestinal stromal tumors – a real-world multi-center study
by: Shaoqing Huang, et al.
Published: (2023-04-01)

Calcinosis tumoral urémica con manifestación atípica. Reporte de caso
by: Arbey Aristizabal-Alzate, et al.
Published: (2022-03-01)

Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls
by: Eleni Gavriilaki, et al.
Published: (2022-06-01)

Fluctuating neurological symptoms: should I call the neurologist or the hematologist?
by: Losa-Rodríguez Rita, et al.
Published: (2020-11-01)

Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report
by: Mihriban İnözü, et al.
Published: (2022-12-01)

THROMBOTIC THROMBOCYTOPENIC PURPURA: OUR CLINICAL EXPERIENCE
by: Zahid Farooq Baig, et al.
Published: (2018-10-01)

Near-fatal cocaine intoxication in an infant with thrombotic microangiopathy associated with multiple organ failure
by: Alejandro Donoso Fuentes, et al.
Published: (2023-08-01)

Thrombotic microangiopathy associated with Valproic acid toxicity
by: Sean A. Hebert, et al.
Published: (2017-08-01)

Regorafenib-induced renal-limited thrombotic microangiopathy: a case report and review of literatures
by: Qinghua Yin, et al.
Published: (2022-03-01)

Traversing Their Path to the Peripheral Smear: The Journey of Traumatized Red Blood Cells
by: Chethana Mannem, et al.
Published: (2023-09-01)

COVID‐19‐induced thrombotic microangiopathy: A great mimicker of thrombotic thrombocytopenic purpura (TTP)
by: Brian Warnecke, et al.
Published: (2023-01-01)

An insidious presentation of thrombotic thrombocytopenic purpura: A case report and brief literature review
by: Shafeek Kiblawi, et al.
Published: (2014-01-01)

Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in a renal transplant recipient case report
by: John Fredy Nieto-Rios, et al.
Published: (2020-11-01)

Patterns of Renal Dysfunction and Profile of Kidney Biopsies in Hematopoietic Stem Cell Transplant Recipients
by: Elenjickal Elias John, et al.
Published: (2023-03-01)

Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy
by: Kentaro Nishi, et al.
Published: (2020-08-01)

Thrombotic microangiopathy associated with lenvatinib therapy
by: Macarena Contreras Angulo, et al.
Published: (2023-04-01)

Three shades of black - secondary thrombotic microangiopathy
by: Rhituparna Das, et al.
Published: (2022-01-01)

A case of gemcitabine-induced thrombotic microangiopathy in a urothelial tumor patient with a single kidney
by: Hyunjin Ryu, et al.
Published: (2015-12-01)

Transplant-associated Thrombotic Microangiopathy Treated with Eculizumab and Romiplostim
by: Muhammad Awidi, et al.
Published: (2021-02-01)

Pegylated Liposomal Doxorubicin and Kidney-Limited Thrombotic Microangiopathy in a Kidney Transplant Recipient: A Case Report
by: Sonia Rodriguez-Ramirez, et al.
Published: (2022-05-01)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
by: Eleni Gavriilaki, et al.
Published: (2019-02-01)

Thrombotic thrombocytopenic purpura (TTP) or Moschowitz syndrome: a true hematologic emergency
by: Deborah Melis, et al.
Published: (2012-01-01)

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study
by: Wolfgang Miesbach, et al.
Published: (2019-11-01)

Second line of therapy for gastrointestinal stromal tumors: is there a choice?
by: L. M. Kogonia, et al.
Published: (2019-06-01)

A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor
by: Maria A. Pantaleo, et al.
Published: (2022-05-01)

Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib
by: Maria Caterina Pallotti, et al.
Published: (2012-12-01)

Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis
by: Anja Gäckler, et al.
Published: (2021-01-01)